Yarrow Bioscience Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +100.0% | +175.0% | +3,081.8% | -51.3% | -68.0% | -33.9% | – | – | +475.0% | |
| – | +781.5% | +153.4% | +150.6% | +84.2% | +170.1% | -55.4% | -46.8% | -23.1% | -0.1% | -30.1% | |
| – | +2,974.4% | -106.5% | – | – | -2,231.7% | – | -52.3% | -97.4% | +8,231.7% | -263.9% | |
| – | – | -12.9% | +418.5% | -92.1% | +927.3% | -100.0% | – | – | – | -100.0% | |
| – | – | -59.8% | +124.9% | – | +115.4% | -98.8% | +1,425.5% | -466.1% | – | +59.9% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +154.4% | -96.0% | +1,137.6% | -35.6% | -95.8% | +4,884.5% | -100.2% | +1.4% | |
| – | -191.4% | – | +536.1% | -147.7% | – | -212.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.